CathWorks
Medical technology company that develops angiography-derived physiologic assessment software for coronary artery disease. The company transforms routine coronary angiograms into 3D coronary models and intraprocedural physiologic metrics using image-processing, computational physiology and machine learning to support interventional decision-making. It has conducted multicenter clinical trials and validation studies, obtained multiple regulatory clearances, and supports clinical implementation, evidence generation and commercial partnerships for market deployment.
Industries
Nr. of Employees
medium (51-250)
Patents
Automated measurement system and method for coronary artery disease scoring
US-12343119-B2
View DetailsVascular characteristic determination based on multiple images identifying a common vascular segment with correspondence modeling of a vascular tree
US-12236600-B2
View DetailsMethods, apparatus, and system for synchronization between a three-dimensional vascular model and an imaging device
US-12039685-B2
View Details
Automated measurement system and method for coronary artery disease scoring
US-12343119-B2
View DetailsVascular characteristic determination based on multiple images identifying a common vascular segment with correspondence modeling of a vascular tree
US-12236600-B2
View DetailsMethods, apparatus, and system for synchronization between a three-dimensional vascular model and an imaging device
US-12039685-B2
View DetailsProducts
Angiogram-derived physiologic assessment system
Software system that converts routine coronary angiograms into 3D coronary models and computes intraprocedural physiologic indices to support lesion-level treatment decisions without invasive pressure wires or pharmacologic hyperemia.
Angiogram-derived physiologic assessment system
Software system that converts routine coronary angiograms into 3D coronary models and computes intraprocedural physiologic indices to support lesion-level treatment decisions without invasive pressure wires or pharmacologic hyperemia.
Services
On-site and remote support for clinical adoption, training of interventional teams, and integration of software outputs into procedural workflows.
Provides educational and research grants or sponsorships to academic institutions, medical centers, professional societies and patient organizations via an application process.
On-site and remote support for clinical adoption, training of interventional teams, and integration of software outputs into procedural workflows.
Provides educational and research grants or sponsorships to academic institutions, medical centers, professional societies and patient organizations via an application process.
Expertise Areas
- Image-based computational coronary physiology
- Clinical trial management and outcomes research
- Medical image reconstruction and 3D quantitative coronary angiography
- Algorithm development for angiographic image analysis
Key Technologies
- Angiography-derived computational fractional flow reserve (computed FFR)
- 3D quantitative coronary angiography (3D QCA)
- Computational physiologic modeling / computational fluid dynamics for coronary physiology
- Machine learning and computer vision for medical imaging
News & Updates
Press report and trial page summarizing the ALL-RISE randomized trial reporting non-inferior major adverse cardiac event (MACE) outcomes at one year for angiography-derived physiologic assessment compared with invasive pressure-wire-guided assessment; results were simultaneously published in the New England Journal of Medicine.
Late-breaking presentation summarizing outcomes for a US cohort of over 4,000 patients assessed with angiography-derived physiologic assessment showing comparable clinical outcomes to invasive pressure wire-guided PCI through two years.
Announcement of regulatory approval under the EU Medical Device Regulation and initiation of co-promotion activities with a commercial partner.
Pooled lesion-level analysis reporting sensitivity, specificity and diagnostic accuracy metrics from multiple prospective validation cohorts comparing angiography-derived physiologic assessment to invasive reference measurements.
Peer-reviewed publication reporting ALL-RISE randomized trial outcomes comparing angiography-derived physiologic assessment with invasive pressure-wire-guided assessment (N Engl J Med).
Reported completion of enrollment for a global randomized controlled trial evaluating angiography-derived physiologic assessment.
Press report and trial page summarizing the ALL-RISE randomized trial reporting non-inferior major adverse cardiac event (MACE) outcomes at one year for angiography-derived physiologic assessment compared with invasive pressure-wire-guided assessment; results were simultaneously published in the New England Journal of Medicine.
Late-breaking presentation summarizing outcomes for a US cohort of over 4,000 patients assessed with angiography-derived physiologic assessment showing comparable clinical outcomes to invasive pressure wire-guided PCI through two years.
Announcement of regulatory approval under the EU Medical Device Regulation and initiation of co-promotion activities with a commercial partner.
Pooled lesion-level analysis reporting sensitivity, specificity and diagnostic accuracy metrics from multiple prospective validation cohorts comparing angiography-derived physiologic assessment to invasive reference measurements.
Peer-reviewed publication reporting ALL-RISE randomized trial outcomes comparing angiography-derived physiologic assessment with invasive pressure-wire-guided assessment (N Engl J Med).
Reported completion of enrollment for a global randomized controlled trial evaluating angiography-derived physiologic assessment.